PRGS Shariah Compliance
Screening Methodology: AAOIFI
NOT HALAL
Last Updated: April 29, 2026
Report Source: 2026 1st Quarter Report
Progress Software Corp. Stock Analysis PRGS
Progress Software Corp. engages in the provision of products that develop and deploy mission-critical business applications. The company is headquartered in Burlington, Massachusetts and currently employs 2,801 full-time employees. The firm provides software products that enable its customers to develop, deploy and manage responsible AI-powered applications and digital experiences. The company also offers retrieval-augmented generation (RAG) -as-a-service products. Its products include Sitefinity, Corticon, MOVEit, ShareFile, Podio, Kendo UI, Telerik, Kemp LoadMaster, Flowmon, WhatsUp Gold, Chef Infrastructure Management, Chef Desktop, Chef App Delivery, MarkLogic, Semaphore, OpenEdge, DataDirect Connectors, Hybrid Data Pipeline, and Automate MFT. MOVEit Transfer Software offers an on-premises Managed File Transfer (MFT) server, supporting compliance with internal governance requirements and regulations. WhatsUp Gold is an information technology (IT) infrastructure monitoring software providing visibility into network devices, servers, virtual machines, cloud, and wireless environments.
Read More Progress Software Corp (PRGS) Chart
Key Statistics of Progress Software Corp (PRGS)
Key statistics in the stock market are essential financial indicators that measure a company's performance, valuation, profitability, and risk.
Today's Range
Today's Open
$27.16Volume
595.11KP/E Ratio (TTM)
14.9552 Week Range
Market Cap
1.22BAvg. Volume
825.20KDividend Yield
0.06%Financial Metrics & Statements of Progress Software Corp (PRGS)
FAQ's for Progress Software Corp (PRGS)
- According to Musaffa’s Shariah screening methodology, Progress Software Corp (PRGS) is currently classified as NOT HALAL as of April 2026. The classification is based on an evaluation of the company’s business activities and financial ratios to determine whether it meets Islamic investment guidelines.